ELDON BIOLOGICALS A/S: Financial statements 2018
CVR: 26747007
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 9,520,051 and a net result of DKK 3,754,766 compared with DKK 2,615,616 the year before. That is an increase of 19.3% compared with the year before. Equity amounted to DKK 7,142,005. The solvency ratio was 57.7%. The company had 7 employees in the financial year.
- Gross Profit
- 9,520,051 kr.
- Profit/Loss
- 3,754,766 kr.
- Equity
- 7,142,005 kr.
- Total Assets
- 12,370,108 kr.
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 9.5 mio. | 3.8 mio. | 7.1 mio. | 7 |
| 2017 | - | 8 mio. | 2.6 mio. | 3.9 mio. | 7 |
| 2016 | - | 6.1 mio. | 1.2 mio. | 1.3 mio. | - |
| 2015 | - | 6.1 mio. | 1.5 mio. | 319 t. | - |
| 2014 | - | 4.9 mio. | 1.1 mio. | -1.2 mio. | - |
Keep an eye on ELDON BIOLOGICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.
